MORAN KEVIN PATRICK (VP, Acting CFO & Treasurer) sold 6.0% of their position (14.70K shares) of VANDA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $63.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/6/2024ACC: 0000950170-24-027253
Officer· VP, Acting CFO & Treasurer
Since Mar 2020
-14.70K
Net shares
Net seller
$63.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
14.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.80K
Price / share
$4.48
Trade value
$25.98K
% of position
2.4%
3/4/2024
245.71K→239.92K
Common Stock
Direct
Shares
−8.90K
Price / share
$4.20
Trade value
$37.41K
% of position
3.7%
3/5/2024
239.92K→231.01K
Total
Net shares
−14.70K
Net value
-$63.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2024 | S · Sale | −5.80K | $4.48 | $25.98K | 2.4% | 245.71K | 239.92K |
| Common Stock Direct | 3/5/2024 | S · Sale | −8.90K | $4.20 | $37.41K | 3.7% | 239.92K | 231.01K |
| Total | −14.70K | -$63.39K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned635.00
Total
635.00 indirect635.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 635.00 | Indirect |
| Total | 635.00 | 635.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported